Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / articles / BICX - BioCorRx Appoints Renowned Investment and Capital Markets Executive Louis Lucido as President | Benzinga


BICX - BioCorRx Appoints Renowned Investment and Capital Markets Executive Louis Lucido as President | Benzinga

  • ANAHEIM, CA, Jan. 09, 2024 (GLOBE NEWSWIRE) -- via NewMediaWireBioCorRx Inc. (OTCQB:BICX) (the "Company"), a developer and provider of innovative treatment programs for substance abuse and related disorders, announced the appointment of Louis Lucido as Interim President of the Company, effective immediately through January 31, 2024, and he will assume the formal role as President on February 1, 2024. Mr. Lucido will remain a Member of the Board of Directors. Additionally, the Company announced that Brady Granier has submitted his letter of resignation as President of BioCorRx Inc. and Chief Executive Officer of BioCorRx Pharmaceuticals, a subsidiary of the Company, effective January 31, 2024. Mr. Granier will continue to serve as a Member of the Company's Board of Directors. Mr. Granier's resignation did not arise as a result of any disagreement with the Company nor BioCorRx Pharmaceuticals.

    Lourdes Felix, CEO, CFO, and Director of BioCorRx Inc., commented, "I am pleased to announce Louis' appointment to Interim President of BioCorRx effective immediately and his transition to President of BioCorRx in February. Lou brings extensive business acumen, having founded and helped run a multi-billion-dollar asset management firm. Louis' breadth of experience in corporate finance and capital markets will be invaluable as we execute our growth strategy and plan for a Nasdaq listing."

    Mr. Lucido has been a Director of BioCorRx Inc. since March 1, 2019. Mr. Lucido was formerly the Senior Advisor and Chief Operating Officer of DoubleLine Group, LP, a large investment firm with over $100 billion in assets under management. He was previously at TCW, where he served as a Group Managing Director. Prior to joining TCW in 2001, Mr. Lucido was the Chief Investment Officer for Delphi Financial Group (DFG) and was on several subsidiary Boards. Before DFG, he was the Chief Operating Officer and Secretary for Hyperion Capital Management and was also a Member of the Resolution Trust Advisory Committee. From 2013-2018, he served as a Member of the Board of Directors of CASA of Los Angeles and Chair. He is a current Member of the Board for National CASA since 2018. Mr. Lucido ...

    Full story available on Benzinga.com

  • Stock Information

    Company Name: BioCorRx Inc.
    Stock Symbol: BICX
    Market: OTC
    Website: biocorrx.com

    Menu

    BICX BICX Quote BICX Short BICX News BICX Articles BICX Message Board
    Get BICX Alerts

    News, Short Squeeze, Breakout and More Instantly...